Login to Your Account



Biogen Idec Earnings Lower Than Wall Street's Forecast

By Aaron Lorenzo


Thursday, March 4, 2004
Reporting for the first time as a combined entity, Biogen Idec Inc. missed consensus earnings estimates by 8 cents, posting pro forma earnings per share of 24 cents for the fourth quarter. Its full-year adjusted EPS totaled $1.22. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription